NPI Details
SOUTHERN LAB PARTNERS, LLC is a clinical medical laboratory in Birmingham, AL. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. SOUTHERN LAB PARTNERS, LLC NPI is 1164775862. The provider is registered as an organization entity type.
The provider's business location address is:
2732 7TH AVE S
BIRMINGHAM, AL
ZIP 35233-406
Phone: (205) 661-0001
Fax: (205) 661-0009
The provider's authorized official is Ashley Potter .
The authorized official title is Partner and has the following contact phone number (205) 661-0001.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0482)
- Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled (HCPCS:P9603)
- Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
- 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0004)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
- Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source (HCPCS:G2024)
- Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
- Blood test, comprehensive group of blood chemicals (HCPCS:80053)
- Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
- Uric acid level, blood (HCPCS:84550)
- Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0480)
- Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
- Bacterial colony count, urine (HCPCS:87086)
- Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
- Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
- Hemoglobin a1c level (HCPCS:83036)
- Bacterial urine culture (HCPCS:87088)
- Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
- Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
- Bacterial culture for aerobic isolates (HCPCS:87077)
- Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique (HCPCS:87581)
- Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique (HCPCS:87486)
- Thyroxine (thyroid chemical), free (HCPCS:84439)
- Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets (HCPCS:87631)
- Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
- Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
- Detection test for gardnerella vaginalis (bacteria), amplified probe technique (HCPCS:87511)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Vitamin d-3 level (HCPCS:82306)
- Magnesium level (HCPCS:83735)
- Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
- Automated urinalysis test (HCPCS:81003)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Thyroid hormone, t3 measurement, free (HCPCS:84481)
- Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge (HCPCS:P9604)
The enumeration date for this NPI number is 10/18/2012 and was last updated on 4/12/2021.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 291U00000X | Clinical Medical Laboratory | | | | Yes |